ARTICLE | Clinical News
Prolacria diquafosol tetrasodium: Phase III data
January 25, 2010 8:00 AM UTC
Top-line data from a North American Phase III (Trial 03-113) trial in 490 patients with a fluorescein staining score of 3 at baseline showed that Prolacria given 4 times daily missed the primary endpo...